Your browser doesn't support javascript.
loading
New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop.
Mahony, Catherine; Ashton, Randolph S; Birk, Barbara; Boobis, Alan R; Cull, Tom; Daston, George P; Ewart, Lorna; Knudsen, Thomas B; Manou, Irene; Maurer-Stroh, Sebastian; Margiotta-Casaluci, Luigi; Müller, Boris P; Nordlund, Pär; Roberts, Ruth A; Steger-Hartmann, Thomas; Vandenbossche, Evita; Viant, Mark R; Vinken, Mathieu; Whelan, Maurice; Zvonimir, Zvonar; Cronin, Mark T D.
Afiliação
  • Mahony C; Procter & Gamble, Egham, Surrey, UK. Electronic address: mahony.c@pg.com.
  • Ashton RS; Department of Biomedical Engineering & Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, 53715, USA. Electronic address: rashton2@wisc.edu.
  • Birk B; BASF SE, Experimental Toxicology and Ecology, Carl-Bosch-Straße 38, 67056, Ludwigshafen, Germany. Electronic address: barbara.birk@basf.com.
  • Boobis AR; National Heart & Lung Institute, Imperial College London, London, W12 0NN, UK. Electronic address: a.boobis@imperial.ac.uk.
  • Cull T; Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK. Electronic address: tom.cull@unilever.com.
  • Daston GP; Mason Business Center, The Procter & Gamble Company, Cincinnati, OH, 45040, USA. Electronic address: daston.gp@pg.com.
  • Ewart L; Veroli Consulting Limited, Cambridge, UK; Emulate Inc, 27 Dry Dock Avenue, Boston, MA, 02210, USA. Electronic address: lorna.ewart@emulatebio.com.
  • Knudsen TB; U.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, Research Triangle Park, NC, 27711, USA. Electronic address: knudsen.thomas@epa.gov.
  • Manou I; European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium. Electronic address: irene.manou@epaaind.eu.
  • Maurer-Stroh S; Innovations in Chemical and Food Safety, Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street #07-01 Matrix, Singapore, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore, 117543, Singapo
  • Margiotta-Casaluci L; College of Health and Life Sciences, Brunel University London, London, UB8 3PH, UK. Electronic address: luigi.margiotta-casaluci@brunel.ac.uk.
  • Müller BP; Symrise AG, Holzminden, Germany. Electronic address: boris.mueller@symrise.com.
  • Nordlund P; Department of Oncology and Pathology, Karolinska Institutet, 17177, Stockholm, Sweden; Institute of Molecular and Cellular Biology, A*STAR, 61 Biopolis Drive, 138673, Singapore. Electronic address: par.nordlund@ki.se.
  • Roberts RA; School of Chemistry, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: r.roberts.4@bham.ac.uk.
  • Steger-Hartmann T; Investigational Toxicology, Bayer AG, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany. Electronic address: thomas.steger-hartmann@bayer.com.
  • Vandenbossche E; Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK. Electronic address: evita.vandenbossche@unilever.com.
  • Viant MR; School of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: m.viant@bham.ac.uk.
  • Vinken M; Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium. Electronic address: mathieu.vinken@vub.be.
  • Whelan M; European Commission, Joint Research Centre (JRC), Italy. Electronic address: maurice.whelan@ec.europa.eu.
  • Zvonimir Z; European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium. Electronic address: zvonimir.zvonar@epaaind.eu.
  • Cronin MTD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. Electronic address: m.t.cronin@ljmu.ac.uk.
Regul Toxicol Pharmacol ; 114: 104668, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32335207
ABSTRACT
The European Partnership for Alternative Approaches to Animal Testing (EPAA) convened a 'Blue Sky Workshop' on new ideas for non-animal approaches to predict repeated-dose systemic toxicity. The aim of the Workshop was to formulate strategic ideas to improve and increase the applicability, implementation and acceptance of modern non-animal methods to determine systemic toxicity. The Workshop concluded that good progress is being made to assess repeated dose toxicity without animals taking advantage of existing knowledge in toxicology, thresholds of toxicological concern, adverse outcome pathways and read-across workflows. These approaches can be supported by New Approach Methodologies (NAMs) utilising modern molecular technologies and computational methods. Recommendations from the Workshop were based around the needs for better chemical safety assessment how to strengthen the evidence base for decision making; to develop, standardise and harmonise NAMs for human toxicity; and the improvement in the applicability and acceptance of novel techniques. "Disruptive thinking" is required to reconsider chemical legislation, validation of NAMs and the opportunities to move away from reliance on animal tests. Case study practices and data sharing, ensuring reproducibility of NAMs, were viewed as crucial to the improvement of non-animal test approaches for systemic toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Toxicidade / Alternativas aos Testes com Animais Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Toxicidade / Alternativas aos Testes com Animais Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article